‹ Today's picks

CLMT (Calumet, Inc. /DE) — AI Stock Analysis & Recommendation

Research of October 20, 2026 · Basic Materials / Petroleum Refining

TradeFlare's AI research teams rate CLMT a HOLD. The latest price is $49.89.

The research plan

  • Entry: $56.05
  • Time horizon: N/A

N/A

Why

Despite a Zacks Rank #1 and strong revenue growth, the fundamental and risk analyses present significant headwinds for CLMT. The deeply negative equity, high leverage, and persistent negative margins, combined with high volatility and solvency concerns, outweigh the positive scanner signal. The technicals are neutral to bearish, and the fundamental team is bearish, leading to a HOLD recommendation.

What could push CLMT higher

  • The AI scanner identified CLMT as a candidate for deep analysis due to a Zacks Rank #1.
  • The company has shown strong revenue growth, indicating potential for operational improvement.
  • Recent earnings reported record performance in specialties and debt reduction.

Key risks for CLMT

  • The company exhibits deeply negative equity and a highly leveraged balance sheet, indicating significant financial distress.
  • Despite revenue growth, CLMT consistently reports negative operating and net margins, suggesting fundamental profitability issues.
  • The stock has high historical and implied volatility, coupled with extreme financial leverage and solvency concerns, making it a high-risk proposition.

What each AI research team found

Fundamental team: Bearish · valuation: overvalued

Calumet Specialty Products Partners, L.P. (CLMT) presents a deeply concerning fundamental picture, characterized by persistent unprofitability, a highly leveraged balance sheet with negative equity, and critically low interest coverage. Despite strong revenue growth, the company's core operations are not generating profits, and its presence in commoditized markets limits pricing power. The current valuation...

  • CLMT exhibits deeply negative equity (-$1.14 billion) and a highly leveraged balance sheet, indicating significant financial distress.
  • Despite strong revenue growth (40.8% YoY), the company consistently reports negative operating (-4.57%) and net (-2.98%) margins, signaling fundamental profitability issues.
  • The extremely high EV/EBITDA of 89.27 and critically low interest coverage proxy (0.26x) suggest the company is overvalued relative to its operating earnings and faces a high risk of default.

Technical team: Neutral

The analysis indicates a neutral short-term outlook for CLMT, with price consolidating near resistance and bearish momentum signals emerging. While the long-term trend remains positive, immediate price action suggests a potential pullback towards the $53.03 support level.

  • Price is consolidating near resistance with short-term moving averages showing bearish crossover, suggesting a potential pullback towards the nearest support level.
  • The stock is consolidating near resistance with mixed volume signals, suggesting a neutral outlook until a clear breakout or breakdown occurs.
  • Bearish momentum is indicated by MACD and Stochastic, with price approaching resistance, suggesting a potential move down towards the nearest support level.

Sentiment team: Neutral

Calumet Specialty Products Partners (CLMT) currently exhibits a neutral sentiment across news, social media, and analyst coverage. While positive developments like record performance and debt reduction are noted, persistent concerns about profitability and mixed analyst ratings temper enthusiasm. The sentiment appears stable, with no clear indication of extreme optimism or pessimism to suggest a contrarian...

  • Calumet's news sentiment is neutral, with a slight negative lean in headline scores, reflecting a mix of positive operational developments like record performance and debt reduction, alongside concerns about persistent losses and capital expenditure adjustments
  • CLMT exhibits a neutral sentiment driven by a mix of positive developments like record performance and strategic expansions, alongside concerns about persistent losses and capital cuts, with a slight negative bias from headline scores
  • Calumet's recent earnings showed record performance in specialties and debt reduction, but concerns remain about persistent losses and capital expenditure cuts, leading to a neutral sentiment with mixed analyst and institutional views. Consensus: Neutral

Risk team: High

CLMT presents a high-risk profile due to extreme financial leverage, negative equity, and critically low interest coverage, compounded by significant historical and implied volatility. The cyclical nature of its business and operational concentration add further layers of risk, necessitating a small position size and aggressive risk management.

  • Extreme Financial Leverage and Solvency Concerns: CLMT exhibits negative equity (-$1.14B) and a very high debt-to-equity proxy (-3.24), coupled with critically low interest coverage (0.26x), indicating significant financial distress and potential solvency issues.
  • High Historical and Implied Volatility: The stock has experienced a deep 1-year drawdown (-61.87%) and shows high realized volatility (20-day: 32.52%, 60-day: 49.75%). Elevated implied volatility (91% IV Rank) suggests market expectations of significant...
  • Cyclical Business Model and Commodity Price Sensitivity: Operating in the energy/materials sector, CLMT is inherently exposed to commodity price fluctuations and demand cyclicality, further amplified by low gross margins and potential overbuilding risks.

CLMT at a glance

Market value$4.6B
Revenue growth (year over year)12.8%
Profit margin-3.0%
Debt / equity-1.99

Every AI call on CLMT since April 21, 2026, and what happened next (30 calls) →

Frequently asked questions

Is CLMT a buy? In its research of October 20, 2026, TradeFlare's AI rated CLMT a HOLD. This is AI-generated research, not financial advice.

When was this analysis last updated? October 20, 2026. Stocks on TradeFlare's lists are re-researched every market night. How the research works.

Research of October 20, 2026 · AI-generated analysis for educational purposes, can be wrong, not financial advice.

AI research, not financial advice. Every score is generated by software and can be wrong. Terms